Cardiac Rehabilitation for Cardiovascular Disease

JT
Overseen ByJenna Taylor, PhD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Mayo Clinic

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial investigates how exercise-based cardiac rehabilitation affects brain blood flow and cognitive function in people with cardiovascular disease. Participants will be divided into groups to receive different exercise programs, such as high-intensity interval training (HIIT) or moderate-intensity continuous training (MICT), and their results will be compared to a control group. The goal is to determine if exercise can improve or maintain cognitive abilities by positively influencing brain blood flow. Individuals who have experienced a cardiac event and are eligible for rehab might be a good fit for this trial. As an unphased trial, this study offers participants the chance to contribute to groundbreaking research that could enhance rehabilitation strategies for cardiovascular patients.

Do I have to stop taking my current medications for this trial?

The trial protocol does not specify whether you need to stop taking your current medications. Please consult with the trial coordinators for more information.

Is there any evidence suggesting that this trial's treatments are likely to be safe?

Research has shown that both high-intensity interval training (HIIT) and moderate-intensity continuous training (MICT) are safe and well-tolerated for people in cardiac rehab. HIIT carries a low risk of serious heart problems in patients with coronary artery disease or heart failure. Studies indicate that HIIT can boost fitness and health without increasing health risks.

Similarly, MICT improves fitness and exercise ability without causing additional heart issues. This training also helps lower death rates and enhances quality of life for those with heart disease. Overall, both exercise programs are considered safe for people in cardiac rehab.12345

Why are researchers excited about this trial?

Researchers are excited about this trial because it explores different styles of cardiac rehabilitation, which could reshape how we approach recovery for cardiovascular disease. Traditional rehab often focuses on moderate exercise, but this study is testing high-intensity interval training (HIIT), which alternates short bursts of intense activity with rest. This method may improve heart health more efficiently and in less time. Additionally, the trial includes an observational group to better understand outcomes in real-world settings. By comparing these approaches, the trial aims to find the most effective way to boost heart recovery and overall fitness.

What evidence suggests that this trial's treatments could be effective for cardiovascular disease?

This trial will compare different cardiac rehabilitation approaches for cardiovascular disease. Research has shown that exercise programs for heart health, such as high-intensity interval training (HIIT) and moderate-intensity continuous training (MICT), can be very beneficial. Participants in this trial may be randomized to receive either HIIT or MICT. Studies have found that HIIT can boost heart fitness and lower the risk of heart disease, sometimes even more effectively than MICT. HIIT is also linked to fewer serious heart problems in individuals with coronary artery disease. Meanwhile, MICT reduces the risk of heart issues and death by focusing on longer, moderate workouts. Both HIIT and MICT are safe and improve overall heart fitness.12346

Who Is on the Research Team?

BD

Bruce D Johnson, PhD

Principal Investigator

Mayo Clinic

Are You a Good Fit for This Trial?

This trial is for people aged 40 and older who are eligible for cardiac rehab after a heart-related hospital stay. It's open to those with coronary artery disease but not to individuals previously diagnosed with cardiovascular diseases or risk factors like high blood pressure, high cholesterol, diabetes, obesity (BMI >30), or smoking.

Inclusion Criteria

I am over 40 and qualify for heart rehab after a heart-related hospital stay.
I am over 40, have never had heart disease, and don't have major heart disease risk factors.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants undergo either high intensity interval training (HIIT) or moderate intensity continuous training (MICT) as part of cardiac rehabilitation

12 weeks
Regular visits as part of cardiac rehabilitation program

Follow-up

Participants are monitored for changes in cerebral blood flow regulation and cognitive function

3 months
Follow-up assessments at 3 months

Observational Control

Participants who decline cardiac rehabilitation are monitored as a control group

12 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Cardiac rehabilitation - control
  • Cardiac rehabilitation - high intensity interval training (HIIT)
  • Cardiac rehabilitation - moderate intensity continuous training (MICT)
  • Cardiac rehabilitation - observational
Trial Overview The study tests how different intensities of exercise in cardiac rehabilitation affect brain blood flow and cognitive function. Participants will be observed during regular control sessions, high intensity interval training (HIIT), and moderate intensity continuous training (MICT).
How Is the Trial Designed?
5Treatment groups
Experimental Treatment
Active Control
Placebo Group
Group I: Cardiac rehabilitation - observationalExperimental Treatment1 Intervention
Group II: Cardiac rehabilitation - High intensity interval training (HIIT)Experimental Treatment1 Intervention
Group III: Healthy control groupActive Control1 Intervention
Group IV: Cardiac rehabilitation - Moderate intensity continuous training (MICT)Active Control1 Intervention
Group V: Cardiac rehabilitation - controlPlacebo Group1 Intervention

Cardiac rehabilitation - control is already approved in European Union, United States, Canada, Japan, China, Switzerland for the following indications:

🇪🇺
Approved in European Union as Cardiac rehabilitation for:
🇺🇸
Approved in United States as Cardiac rehabilitation for:
🇨🇦
Approved in Canada as Cardiac rehabilitation for:
🇯🇵
Approved in Japan as Cardiac rehabilitation for:
🇨🇳
Approved in China as Cardiac rehabilitation for:
🇨🇭
Approved in Switzerland as Cardiac rehabilitation for:

Find a Clinic Near You

Who Is Running the Clinical Trial?

Mayo Clinic

Lead Sponsor

Trials
3,427
Recruited
3,221,000+

Published Research Related to This Trial

A study involving 40 patients with coronary artery disease showed that both standard cardiac rehabilitation and high-intensity interval training (HIIT) significantly improved functional capacity, lipid profiles, and quality of life after percutaneous coronary intervention.
HIIT was found to be at least as safe and effective as standard moderate-intensity exercise, with additional benefits in emotional well-being, highlighting its potential as a valuable alternative in cardiac rehabilitation programs.
High intensity interval training exercise as a novel protocol for cardiac rehabilitation program in ischemic Egyptian patients with mild left ventricular dysfunction.Abdelhalem, AM., Shabana, AM., Onsy, AM., et al.[2022]
Many leading cardiac rehabilitation guidelines from North America and Europe advocate for a progression from moderate- to vigorous-intensity aerobic exercise, along with resistance training, to enhance patient outcomes and quality of life.
Higher-intensity aerobic training is considered safe for cardiac rehabilitation patients and may lead to better results, suggesting a need for international consensus on exercise prescription in these programs.
A review of guidelines for cardiac rehabilitation exercise programmes: Is there an international consensus?Price, KJ., Gordon, BA., Bird, SR., et al.[2022]
High-intensity interval training (HIIT) is as effective, if not more so, than traditional moderate-intensity continuous training (MICT) for patients with cardiovascular disease, based on a systematic review of 23 studies involving 1117 participants.
The safety profile of HIIT in cardiac rehabilitation is promising, with only one major cardiovascular adverse event reported per 17,083 training sessions, indicating that HIIT can be safely implemented in this population.
High-Intensity Interval Training for Patients With Cardiovascular Disease-Is It Safe? A Systematic Review.Wewege, MA., Ahn, D., Yu, J., et al.[2021]

Citations

High-Intensity Interval Training in Cardiac Rehabilitation - PMCHIIT has been found to be as effective, if not superior, to MICT with respect to improving clinical outcomes for older patients with CVD.
2.pubmed.ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.gov/36753063/
High-intensity interval training in cardiac rehabilitation (HIIT ...Conclusions: In stable CAD, low-volume HIIT improved cardiorespiratory fitness more than MISS by a clinically meaningful margin. Low-volume HIIT ...
High‐Intensity Interval Training for Patients With ...HIIT has shown a relatively low rate of major adverse cardiovascular events for patients with coronary artery disease or heart failure when applied within CR ...
Cost-effectiveness of High-Intensity Interval Training (HIIT) ...In a recent randomized controlled trial, high-intensity interval exercise training (HIIT) was more effective than moderate intensity steady-state (MISS) ...
High-intensity interval training in cardiac rehabilitation: a multi ...The primary outcome was the change in cardiorespiratory fitness [peak oxygen uptake (VO2 peak)] at 8 week follow-up. Secondary outcomes included ...
Short-term and Long-term Feasibility, Safety, and Efficacy ...This randomized clinical trial compares high-intensity interval training with moderate-intensity continuous training for feasibility, safety ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security